Login to Your Account



UNIQUE GLOBAL BIOLOGICAL QUALIFIER + SHARED INN

World Health Organization explores hybrid biosimilar naming scheme

By Mari Serebrov
Washington Editor

Monday, January 27, 2014
regulatory.jpg
While still a long way from solving the problem of how to name biosimilars, a World Health Organization (WHO) expert group is looking at a hybrid proposal that straddles the fence between conflicting calls for unique or shared international nonproprietary names (INNs).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription